Atlas Trials

Comparative Atorvastatin Pleiotropic Effects

Clinical trial NCT00163202 · COMPLETED

Trial details

NCT number
NCT00163202
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Coronary ArteriosclerosisHypercholesterolemia
Start date
2002-06-01
Enrollment
330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.